Analysis of 18FDG-PET/CT in Patients with Pancreatic Neuroendocrine Tumor Abstract #1340

Introduction: Neuroendocrine Tumor (pNET) comprised a wide and heterogeneous group of neoplasms. 18FDG-PET/CT was the most widely used functional imaging for cancer in general and had a high accuracy for poorly differentiated NENs.
Aim(s): This study aimed to analyze the special performance of 18FDG-PET/CT in pNET patients and to assess the correlation between glucose metabolism and differentiation degree of tumor.
Materials and methods: 40 pNET patients (20 males, 20 females, age: 19-77 years) with histologically proven were enrolled in the study. All the patients had primary lesions or metastases.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Jiangyuan Yu
Authors: Yu J, Yang Z, Fan Y, Lu M, Li J

To read results and conclusion, please login ...

Further abstracts you may be interested in

#143 Association of somatostatin receptor 2 immunohistochemical expression with [111In]-DTPA octreotide scintigraphy and [68Ga]-DOTATOC PET/CT in neuroendocrine tumors
Introduction: In the absence of preoperative somatostatin receptor (sst) scans, knowledge of immunohistochemical sst2 tumor expression may help in predicting the success of somatostatin analogue-based follow-up studies and treatment of neuroendocrine tumors (NETs).
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr. Karsten Müssig
#863 Assessment of Neuroendocrine Tumors' Heterogeneity with Combination of Molecular Imaging Studies
Introduction: Neuroendocrine tumors (NET) are heterogeneous neoplasms. The choice of the appropriate molecular imaging study for assessment of disease extent usually depends on tumor grade.
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: MD Roberta E Rossi
#873 The Analysis of Immunohistochemistry Staining, Neuronspecific Enolase (NSE) Level and Somatostatin Receptor Scintigraphy of Gastroenteropancreatic Neuroendocrine Neoplasm Cases
Introduction: 99mTc-HYNIC-TYR3-OCTREOTIDE somatostatin receptor (SSR) scintigraphy has been used to diagnose gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN).
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Jiangyuan Yu
Authors: Yu J, Li J, Yang Z, ...
#1051 An Intrapatient Comparison of 99mTc-HYNIC-TOC with 68Ga-DOTA-TATE for Imaging Abilities of Gastroenteropancreatic Neuroendocrine Neoplasms
Introduction: Imaging with 68Ga-labled somatostatin analogs provides some advantages over SRS imaging, and has therefore recently become more poprlar.
Conference: 12th Annual ENETS Conference 2015 (2015)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Yu Jiangyuan
Authors: Yu J, Li J, Yang Z, ...
#1304 Analysis of 18FDG-PET/CT in Patients with Gastrointestinal Neuroendocrine Neoplasm
Introduction: Gastrointestinal neuroendocrine neoplasm (Gi-NEN) comprised a wide and heterogeneous group of neoplasms. Diagnosis could often be challenging due to their rarity. 18FDG-PET/CT had a high accuracy for poorly differentiated NENs.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Jiangyuan Yu
Authors: Yu J, Yang Z, Fan Y, Lu M, ...